{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:38:36Z","timestamp":1792597116335,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cll.2026.07.006","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:13:23Z","timestamp":1786493603000},"page":"755-768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Drug Monitoring of Immunosuppressants in Cardiac Transplantation"],"prefix":"10.1016","volume":"46","author":[{"given":"Preejith P.","family":"Vachali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2026.07.006_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/phar.2716","article-title":"Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: endorsed by the American college of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation","volume":"42","author":"Nelson","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cll.2026.07.006_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0000000000001250","article-title":"Everolimus personalized therapy: second consensus report by the International Association of Therapeutic Drug monitoring and clinical toxicology","volume":"47","author":"Masuda","year":"2025","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cll.2026.07.006_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/FTD.0000000000000260","article-title":"Therapeutic drug monitoring of everolimus: a consensus report","volume":"38","author":"Shipkova","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cll.2026.07.006_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cll.2026.07.006_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/FTD.0000000000000269","volume":"38","author":"Seger","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cll.2026.07.006_bib7","series-title":"Astagraf XL (tacrolimus extended-release) prescribing information","year":"2023"},{"key":"10.1016\/j.cll.2026.07.006_bib8","series-title":"Prograf (tacrolimus) prescribing information","year":"2022"},{"key":"10.1016\/j.cll.2026.07.006_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.12.027","article-title":"Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry","volume":"454","author":"McShane","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cll.2026.07.006_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22357","article-title":"Performance of the Dimension TAC assay and comparison of multiple platforms for the measurement of tacrolimus","volume":"32","author":"Cho","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.cll.2026.07.006_bib11","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ajt.12809","article-title":"Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial","volume":"14","author":"Andreassen","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib12","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1016\/j.healun.2005.01.010","article-title":"Recommendations for use of certican (everolimus) after heart transplantation: results from a German and Austrian consensus conference","volume":"24","author":"Hummel","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40262-019-00846-1","article-title":"Clinical pharmacokinetics and impact of hematocrit on monitoring and dosing of tacrolimus early after heart and lung transplantation","volume":"59","author":"Sikma","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cll.2026.07.006_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13318-017-0453-7","article-title":"Association of whole blood tacrolimus concentrations with kidney injury in heart transplantation patients","volume":"43","author":"Sikma","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.cll.2026.07.006_bib15","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.healun.2021.01.1794","article-title":"Tacrolimus time in therapeutic range is associated with cellular rejection and gut dysbiosis early after heart transplant","volume":"40","author":"Bohn","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib16","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1111\/ajt.15016","article-title":"High tacrolimus trough level variability is associated with rejections after heart transplant","volume":"18","author":"Gueta","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2025.1716789","article-title":"Comparative evaluation of five tacrolimus assays in transplant recipients: implications for optimizing therapeutic drug monitoring","volume":"4","author":"SahBandar","year":"2025","journal-title":"Front Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jalm\/jfaf199","article-title":"Tacrolimus assay comparison: analytical and operational considerations for immunoassay vs mass spectrometry testing in a high volume clinical laboratory","volume":"11","author":"Goldblatt","year":"2026","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cll.2026.07.006_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1258\/000456302320314502","article-title":"Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry","volume":"39","author":"Keevil","year":"2002","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.cll.2026.07.006_bib20","doi-asserted-by":"crossref","first-page":"S515","DOI":"10.1016\/j.healun.2024.02.726","article-title":"Is targeting lower tacrolimus levels during the first year after heart transplant safe\/effective?","volume":"43","author":"Kittleson","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s13318-018-0483-9","article-title":"Pharmacokinetics of the novel, selective, non-steroidal mineralocorticoid receptor antagonist finerenone in healthy volunteers: results from an absolute bioavailability study and drug-drug interaction studies in vitro and in vivo","volume":"43","author":"Heinig","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.cll.2026.07.006_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41397-024-00325-2","article-title":"Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients","volume":"24","author":"Liu","year":"2024","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.cll.2026.07.006_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40262-019-00854-1","article-title":"Unbound plasma, total plasma, and whole-blood tacrolimus pharmacokinetics early after thoracic organ transplantation","volume":"59","author":"Sikma","year":"2020","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 10","key":"10.1016\/j.cll.2026.07.006_bib24","first-page":"51","article-title":"Cytomegalovirus","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/FTD.0000000000000376","article-title":"Therapeutic drug monitoring of everolimus: comparability of concentrations determined by 2 immunoassays and a liquid chromatography tandem mass spectrometry method","volume":"39","author":"Shipkova","year":"2017","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cll.2026.07.006_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/14622416.2025.2489920","article-title":"Survey of the utilization of genotype-guided tacrolimus management in United States solid organ transplant centers","volume":"26","author":"Strother","year":"2025","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cll.2026.07.006_bib27","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.healun.2017.01.155","article-title":"Effect of ABCB1 haplotypes on tacrolimus disposition in heart transplant recipients","volume":"36","author":"Oreschak","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/phar.2601","article-title":"Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients","volume":"41","author":"Leino","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cll.2026.07.006_bib29","first-page":"319","article-title":"Evaluating the impact of CYP3A5 genotype on post-transplant healthcare resource utilization in pediatric renal and heart transplant recipients receiving tacrolimus","volume":"14","author":"Pasternak","year":"2021","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.cll.2026.07.006_bib30","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1515\/cclm-2023-1063","article-title":"Analytical performance specifications for measurement uncertainty in therapeutic monitoring of immunosuppressive drugs","volume":"62","author":"Cattaneo","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cll.2026.07.006_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s13318-018-0478-6","article-title":"Impact of the CYP3A5\u22171 allele on the pharmacokinetics of tacrolimus in Japanese heart transplant patients","volume":"43","author":"Uno","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.cll.2026.07.006_bib32","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s40262-024-01414-y","article-title":"Model-informed precision dosing of tacrolimus: a systematic review of population pharmacokinetic models and a benchmark study of software tools","volume":"63","author":"Hoffert","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cll.2026.07.006_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.healun.2024.12.021","article-title":"Machine learning model for tacrolimus dosing: can we validate and compare to existing options?","volume":"44","author":"Shashaty","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cll.2026.07.006_bib34","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.3390\/ijms26136358","article-title":"Analytical validation of an LC-MS\/MS method for simultaneous quantification of multiple immunosuppressants in microvolume whole blood","volume":"26","author":"Aizawa","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cll.2026.07.006_bib35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10337-025-04421-8","article-title":"Automated extraction and quantification of immunosuppressants and anticonvulsants from dried blood spots: evaluation of transcend DBSA\u2013TLX-1\u2013MS\/MS system","volume":"88","author":"Sharma","year":"2025","journal-title":"Chromatographia"},{"key":"10.1016\/j.cll.2026.07.006_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4939-8823-5_11","article-title":"Simultaneous determination of tacrolimus and cyclosporine A in whole blood by ultrafast LC-MS\/MS","volume":"1872","author":"Bjergum","year":"2019","journal-title":"Methods Mol Biol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:41:07Z","timestamp":1792593667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271226000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0272271226000764"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2026.07.006","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Drug Monitoring of Immunosuppressants in Cardiac Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2026.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}